Počet záznamů: 1
Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
- 1.0519574 - ÚOCHB 2020 RIV eng P - Patentový dokument
Jansa, Petr - Holý, Antonín - Zídek, Zdeněk - Kmoníčková, Eva - Janeba, Zlatko
Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof.
2019. Vlastník: Ústav organické chemie a biochemie AV ČR, v. v. i. - Ústav experimentální medicíny AV ČR, v. v. i. Datum udělení patentu: 04.09.2019. Číslo patentu: EP3195867
Grant CEP: GA TA ČR(CZ) TE01020028
Institucionální podpora: RVO:61388963 ; RVO:68378041
Klíčová slova: pyrimidine compounds * prostaglandin E2 * nitric oxide
Obor OECD: Organic chemistry; Pharmacology and pharmacy (UEM-P)
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20190904&DB=&locale=en_EP&CC=EP&NR=3195867B1&KC=B1&ND=4#
The invention provides pyrimidine compounds of general formula (I), which reduce simultaneously the production of nitric oxide (NO) and prostaglandin E2 (PGE2). They have no negative effect on the viability of cells in concentrations decreasing the production of these factors by up to 50%, they are not cytotoxic. Furthermore, a method of preparation of the pyrimidine compounds of general formula (I), carrying 2-formamido group, a pharmaceutical composition comprising the substituted pyrimidine compounds according to the invention, and the use of these compounds for the treatment of inflammatory and cancer diseases are provided.
Trvalý link: http://hdl.handle.net/11104/0304712
Název souboru Staženo Velikost Komentář Verze Přístup 0519574.pdf 9 2.3 MB Jiná povolen
Počet záznamů: 1